Inhibiting STAT-1 signaling in hepatocytes prevented NASH development, but had no effect on HCC occurrence, and conversely, blocking STAT-3 prevented HCC without affecting NASH, potentially providing a mechanistic basis for HCC development independent of fibrosis and NASH with hepatocyte signaling critically involved. This evidence concerns the gene STAT3 and metabolic dysfunction-associated steatohepatitis.